Half-year report · HY
2689.TEDINET S100XKW2
Period2025-07-01 → 2025-12-31
Filed2026-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥62.4bn | 2025-07-01 → 2025-12-31 | Cons. | Net sales |
| Revenue | ¥122.7bn | 2024-07-01 → 2025-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥60.6bn | 2024-07-01 → 2024-12-31 | Cons. | Net sales |
| Operating income | ¥674m | 2025-07-01 → 2025-12-31 | Cons. | Operating income |
| Operating income | ¥808m | 2024-07-01 → 2024-12-31 | Cons. | Operating income |
| Ordinary income | ¥675m | 2025-07-01 → 2025-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.0bn | 2024-07-01 → 2025-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥824m | 2024-07-01 → 2024-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥695m | 2025-07-01 → 2025-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥816m | 2024-07-01 → 2024-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥451m | 2025-07-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.4bn | 2024-07-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥648m | 2024-07-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥451m | 2025-07-01 → 2025-12-31 | Cons. | Profit loss |
| Net income | ¥648m | 2024-07-01 → 2024-12-31 | Cons. | Profit loss |
| Total assets | ¥48.1bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥45.9bn | at 2025-06-30 | Cons. | Assets |
| Total assets | ¥46.8bn | at 2024-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥36.0bn | at 2025-12-31 | Cons. | Liabilities |
| Total liabilities | ¥33.6bn | at 2025-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥12.2bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥12.3bn | at 2025-06-30 | Cons. | Net assets |
| Net assets / equity | ¥11.5bn | at 2024-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.9bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.5bn | at 2025-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.9bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.4bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.6bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.7bn | at 2024-06-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥772m | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.6bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥800m | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥977m | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.6bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥889m | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.2bn | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥687m | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.5bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥76.02 | 2025-07-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥241.43 | 2024-07-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥109.44 | 2024-07-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 25.3% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.7% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 24.6% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-07-01 → 2025-12-31 | −¥966m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-07-01 → 2025-12-31 | −¥966m |
| Reconciling Itemsreconciling | segment profit | 2025-07-01 → 2025-12-31 | −¥68m |
| Care Nursing Goodsreportable segment | revenue | 2025-07-01 → 2025-12-31 | ¥1.5bn |
| Care Nursing Goodsreportable segment | revenue external | 2025-07-01 → 2025-12-31 | ¥1.5bn |
| Care Nursing Goodsreportable segment | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥114,000 |
| Care Nursing Goodsreportable segment | segment profit | 2025-07-01 → 2025-12-31 | ¥122m |
| Medical Equipmentreportable segment | revenue | 2025-07-01 → 2025-12-31 | ¥58.9bn |
| Medical Equipmentreportable segment | revenue external | 2025-07-01 → 2025-12-31 | ¥58.0bn |
| Medical Equipmentreportable segment | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥900m |
| Medical Equipmentreportable segment | segment profit | 2025-07-01 → 2025-12-31 | ¥555m |
| SPDreportable segment | revenue | 2025-07-01 → 2025-12-31 | ¥3.0bn |
| SPDreportable segment | revenue external | 2025-07-01 → 2025-12-31 | ¥3.0bn |
| SPDreportable segment | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥66m |
| SPDreportable segment | segment profit | 2025-07-01 → 2025-12-31 | ¥64m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-07-01 → 2025-12-31 | ¥63.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-07-01 → 2025-12-31 | ¥62.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥966m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-07-01 → 2025-12-31 | ¥742m |
| Reconciling Itemsreconciling | revenue | 2024-07-01 → 2024-12-31 | −¥880m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-07-01 → 2024-12-31 | −¥880m |
| Reconciling Itemsreconciling | segment profit | 2024-07-01 → 2024-12-31 | −¥67m |
| Care Nursing Goodsreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥1.4bn |
| Care Nursing Goodsreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥1.4bn |
| Care Nursing Goodsreportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥19,000 |
| Care Nursing Goodsreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥105m |
| Medical Equipmentreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥57.3bn |
| Medical Equipmentreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥56.5bn |
| Medical Equipmentreportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥816m |
| Medical Equipmentreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥715m |
| SPDreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥2.8bn |
| SPDreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥2.8bn |
| SPDreportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥64m |
| SPDreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥55m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-07-01 → 2024-12-31 | ¥61.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-07-01 → 2024-12-31 | ¥60.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥880m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-07-01 → 2024-12-31 | ¥875m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 534
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任 あずさ監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)鈴 木 重 久 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)炭 廣 慶 行 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1InterimDuration | 60627694000 | JPY |
| Net sales (5-year summary) | InterimDuration | 62444669000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 122702463000 | JPY |
| Ordinary income loss (5-year summary) | Prior1InterimDuration | 824265000 | JPY |
| Ordinary income loss (5-year summary) | InterimDuration | 675487000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 1962447000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1InterimDuration | 648158000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | InterimDuration | 450566000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 1430099000 | JPY |
| Comprehensive income (5-year summary) | Prior1InterimDuration | 643619000 | JPY |
| Comprehensive income (5-year summary) | InterimDuration | 386984000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 1397056000 | JPY |
| Net assets (5-year summary) | Prior1InterimInstant | 11502258000 | JPY |
| Net assets (5-year summary) | InterimInstant | 12153904000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 12255637000 | JPY |
| Total assets (5-year summary) | Prior1InterimInstant | 46776191000 | JPY |
| Total assets (5-year summary) | InterimInstant | 48111991000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 45871212000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1InterimDuration | 109.44 | |
| Basic earnings loss per share (5-year summary) | InterimDuration | 76.02 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 241.43 | |
| Diluted earnings per share (5-year summary) | Prior1InterimDuration | － | |
| Diluted earnings per share (5-year summary) | InterimDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1InterimInstant | 0.246 | |
| Equity to asset ratio (5-year summary) | InterimInstant | 0.253 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.267 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1InterimDuration | -799607000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | InterimDuration | -771514000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 1626920000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1InterimDuration | -888603000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | InterimDuration | -976851000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -1635697000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1InterimDuration | 1539633000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | InterimDuration | 1182667000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 686949000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1InterimInstant | 2593270000 | JPY |
| Cash and cash equivalents (5-year summary) | InterimInstant | 2856109000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 3420020000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 6250000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 6250000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 6250000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 6250000 | |
| Number of shares held | InterimInstant_No1MajorShareholdersMember | 859000 | |
| Shareholding ratio | InterimInstant_No1MajorShareholdersMember | 0.1391 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |